VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
IXHL
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
IXHLIncannex Healthcare Limited
$3.62$42M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksIXHLQuarterly Financials

Incannex Healthcare Limited (IXHL) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Incannex Healthcare Limited (IXHL) quarterly income statement — complete revenue, gross profit & net income history

IXHL Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ2'26Q4'25Q2'25Q4'24Q2'24Q4'23Q2'23Q4'22Q2'22Q4'21Q2'21Q4'20Q2'20Q4'19Q2'19Q4'18Q2'18Q4'17Q2'17Q4'16
Sales/Revenue066.62K012K-5.96K00392.57K392.58K360.01K591.43K215.69K3.66K777.07K186.42K761.92K257.83K132.83K8.68K43.06K
Revenue Growth %-455.13%100%---100%-100%9.05%-33.62%66.91%16054.79%-72.24%-98.04%1.99%-27.7%473.62%2869.07%208.46%220.74%-
Cost of Goods Sold0179.82K017K86K81.75K49.56K84.27K-77.94K186.91K270.27K198.36K4.21K459.88K123.3K175.01K89.18K253.76K5.41K32.78K
COGS % of Revenue-269.93%-141.67%-1441.74%--21.47%-19.85%51.92%45.7%91.97%114.97%59.18%66.14%22.97%34.59%191.04%62.33%76.13%
Gross Profit0-128.37K012K-5.96K-81.75K-49.56K308.3K470.49K173.1K321.16K17.32K-547534.14K63.12K205.95K79.47K-120.93K3.27K10.28K
Gross Margin %--192.7%-100%100%--78.53%119.85%48.08%54.3%8.03%-14.94%68.74%33.86%27.03%30.82%-91.04%37.67%23.87%
Gross Profit Growth %--1169.76%100%114.68%87.96%-126.52%-110.53%78.1%46.5%899.26%58812.61%-96.76%-100.87%159.35%-20.58%270.31%2329.65%-1276.69%20.81%-
Operating Expenses7M18.63M5M9.76M11.7M11.8M3.65M3.83M2.25M3.39M2.22M1.73M931.98K2.73M655.88K1.04M1.43M721.18K483.63K269.1K
OpEx % of Revenue-27960.25%-81300%-196125.8%--976.73%572.4%941.48%375.72%802.13%25456.92%351.85%351.82%136.46%556.34%542.95%5569.23%624.92%
Selling, General & Admin4.71M9.53M2.27M7.93M7.83M5.26M5.15M9.13M1.04M5.09M2.6M1.73M441.59K1.95M655.88K3.09M551.82K552.29K2.2M538.19K
SG&A % of Revenue-14299.87%-66047.06%-131315.59%--2326.8%266%1415.09%439.79%802.13%12061.95%251.56%351.82%405.69%214.02%415.8%25294.88%1249.84%
Research & Development2.28M9.33M2.73M6.53M3.87M3.63M3.32M1.49M1.2M1.35M1.02M0156.12K0000000
R&D % of Revenue-14010.15%-54382.15%-64810.19%--379.51%306.56%376.15%173.23%-4264.38%-------
Other Operating Expenses0-233K0-1000K01000K-1000K-1000K-661-1000K-1000K0334.27K779.34K0-1000K882.61K168.89K-1000K-269.1K
Operating Income-7M-18.79M-5M-7.42M-11.7M-9.11M-7.8M-3.53M-6.08M-3.22M-3.6M-1.71M-932.53K-998.34K-1.19M-1.67M-1.35M-842.24K-480.36K-258.82K
Operating Margin %--28200.43%--61791.67%196125.8%---898.24%-1549.53%-893.35%-608.97%-794.1%-25471.91%-128.47%-635.92%-218.85%-525.52%-634.09%-5531.56%-601.05%
Operating Income Growth %-39.82%-153.35%57.24%18.62%-50.07%-158.4%-28.15%-9.64%-68.9%-87.78%-286.22%-71.56%21.34%40.13%12.51%-97.98%-182.07%-225.42%-589.16%-
EBITDA-6.94M-18.74M-5.01M-7.32M-11.68M-9.03M-7.75M-168.61K-3.75M-17.33K201.16K-1.67M-923.08K-976.86K-1.18M-1.66M-1.33M-813.25K-477.62K-253.1K
EBITDA Margin %--28136.69%--61018.17%195831%---42.95%-954.65%-4.81%34.01%-772.74%-25213.9%-125.71%-630.88%-217.85%-517.75%-612.27%-5499.99%-587.77%
EBITDA Growth %-38.5%-155.98%57.13%18.93%-50.8%-5256.75%-106.69%-873.16%-1963.03%98.96%121.79%-70.62%21.51%41.15%11.9%-104.1%-179.5%-221.32%-608.33%-
D&A (Non-Cash Add-back)59K42.46K-5K92.82K17.59K79.77K49.56K3.36M2.34M3.2M3.8M46.08K9.45K21.48K9.4K7.61K20.02K28.99K2.74K5.72K
EBIT-6.52M-39.09M-3.84M-7.35M-7.7M-9.11M-58.98M-14.21M-2.34M-3.2M-3.6M-1.71M-932.53K-997.84K-601.88K-1.82M-1.5M-20.67M-483.1K-264.54K
Net Interest Income5K-98K-128K59.88K29.31K197.37K117.82K5.61K9133869583.48K1.46K-2.87K-35.35K-3.4K-1.78K-8.4K-11.83K225
Interest Income5K34K4K59.88K29.31K197.37K117.82K5.61K9133861.79K3.48K1.46K1.25K00000225
Interest Expense0132K132K0000000839004.13K35.35K3.4K1.78K8.4K11.83K0
Other Income/Expense474K-25.89M1.03M64K4.02M80.27M1.54M-1.32M790.43K-557.13K1.8K86.44K-26.57K-437.46K-135.01K-80.66K-138.1K-123.94K-9.07M-27.92K
Pretax Income-6.52M-44.67M-3.97M-7.35M-7.68M71.16M-6.25M-4.85M-5.29M-3.77M-3.6M-1.63M-959.1K-1.44M-1.32M-1.75M-1.49M-966.29K-9.55M-286.74K
Pretax Margin %--67060.47%--61258.33%128760.52%---1234.43%-1348.19%-1048.1%-608.66%-753.96%-26197.71%-184.71%-708.34%-229.44%-579.08%-727.48%-109947.55%-665.88%
Income Tax00030K000000000-71-155.51K-159.93K267.02K-195.82K-152.55K0
Effective Tax Rate %0%0%0%-0.41%0%0%0%0%0%0%0%0%0%0%11.78%9.15%-17.88%20.26%1.6%0%
Net Income-6.52M-35.57M-3.97M-6.46M-5.24M-67.21M-144.62M-4.85M-5.29M-3.77M-1.92M-2.35M-1.1M-2.13M-591.52K-1.82M-613.47K-966.29K-9.4M-286.74K
Net Margin %--53398.58%--53841.67%87862.53%---1234.43%-1348.19%-1048.1%-324.59%-1091.8%-30096.18%-274.29%-317.3%-238.95%-237.93%-727.48%-108190.86%-665.88%
Net Income Growth %-64.34%-450.56%24.29%90.39%96.38%-1287%-2632.54%-28.43%-175.7%-60.23%-74.23%-10.48%-86.27%-17.07%3.58%-88.41%93.47%-237%-11396.65%-
Net Income (Continuing)-6.52M-35.57M-3.97M-10.78M-726K-67.21M-144.62M-4.85M-5.29M-3.77M-1.92M-1.63M-959.1K-2.13M-1.33M-1.72M-1.22M-966.29K-9.4M-286.74K
Discontinued Operations00000000000-727.84K-142.72K0000000
Minority Interest00000000000000000000
EPS (Diluted)-0.60-0.69-0.64-1.14-0.08-13.74-0.57-0.47-0.27-0.43-0.25-0.39-0.180.12-0.20-0.39-0.40-0.67-13.32-0.39
EPS Growth %6.25%39.47%-700%91.7%85.96%-2823.4%-111.11%-9.3%-8%-10.26%-38.89%-425%10%130.77%50%41.79%97%-71.79%-5023.08%-
EPS (Basic)-0.60-0.69-0.64-1.14-0.08-13.74-0.57-0.47-0.27-0.43-0.25-0.39-0.180.16-0.20-0.39-0.40-0.67-13.32-0.39
Diluted Shares Outstanding11.65M10.34M5.87M5.68M5.29M5.21M5.13M10.29M9.57M8.77M7.52M5.99M5.41M4.85M2.93M2.27M1.53M1.43M696.59K735.91K
Basic Shares Outstanding11.65M10.34M5.87M5.68M5.29M5.21M5.13M10.29M9.57M8.77M7.52M5.99M5.41M3.57M2.93M2.27M1.53M1.43M696.59K735.95K
Dividend Payout Ratio--------------------